Axelrod Research
Archives
Search...
Log in
Subscribe
Axelrod Research — LMT: $230bn of Backlog Still Supports Buying at $506.50
October 2, 2026
No new stock research qualified in today’s noon-to-noon review window, so the right use of the quiet day is to re-underwrite a live thesis rather than...
Axelrod Research — WFC: A Risk-Chief Change Is Not an $80.48 Buy Thesis
September 30, 2026
The risk-chief transition does not change Wells Fargo’s earnings power on the evidence available. At a $80.48 close on 29 September 2026, the right decision...
Axelrod Research — ANET: The Thesis Holds, but $205 Is Not an Entry
September 29, 2026
Arista’s AI-networking thesis is intact, but the price has outrun the evidence. ANET closed at $204.92 on 28 September 2026, 33.0% above the $154.03 price on...
Axelrod Research — MSFT: Xbox Cuts Do Not Justify Chasing $516
September 27, 2026
Microsoft’s 268-job Xbox restructuring is a cost action, not evidence that Microsoft’s earnings power has stepped up. At $516.17 at the 25 September 2026...
Axelrod Research — RCL: A $3bn Deal Rumor Is Not an Investment Case
September 26, 2026
The actionable point today is restraint: a purported $3bn Royal Caribbean transaction is large enough to reshape the balance-sheet debate, yet today's...
Axelrod Research — DB: A $35.62 Price Still Needs Earnings Proof
September 25, 2026
Deutsche Bank’s reported commodities rebuild remains a story about hires, not yet a story about earnings. With the ADR closing at $35.62 on 24 September...
Axelrod Research — MRK: A 5.1% Pullback Still Does Not Close the Evidence Gap
September 24, 2026
Merck is cheaper than at the last review, but the evidence has not caught up with the price. MRK closed at $148.08 on 23 September 2026, 5.1% below the...
Axelrod Research — GOOGL: A $351 Price Still Needs an Earnings Thesis
September 23, 2026
The live question is not whether Alphabet owns important AI infrastructure; it is whether the evidence in hand supports paying today’s price for it. It does...
Axelrod Research — LMT: The $58.6bn Patriot Backlog Still Supports a Buy
September 22, 2026
No new company evidence landed in today’s research window, so the useful decision is whether Lockheed Martin’s existing case still clears the bar. It does:...
Axelrod Research — XOM: A 1.5% Pullback Still Does Not Create an Entry
September 21, 2026
XOM has slipped from the $166 level in my last review to $163.54 at the 18 September 2026 close, but the investment case has not improved enough to warrant...
Axelrod Research — NVDA: A $12.9bn Rumor Is Still Not a Buy Thesis
September 18, 2026
The archived NVDA catalyst still fails the most basic underwriting test: there is no captured primary confirmation that NVIDIA agreed to buy Hugging Face for...
Axelrod Research — LMT: The Patriot Backlog Still Supports Buying Below $600
September 17, 2026
The Patriot thesis remains intact, and the market is still offering the shares below the level where the production ramp becomes fully priced. With no new...
Axelrod Research — ANET: The Thesis Works, but $188 Is No Longer an Entry
September 15, 2026
Arista’s operating thesis still works; the stock’s setup does not. ANET closed at $187.81 on 14 September 2026, 21.9% above the $154.03 price at which the...
Axelrod Research — SNEX: The $1.6 Quadrillion TAM Still Is Not Revenue
September 5, 2026
The price has barely moved, and neither has the proof. StoneX closed at $69.46 on September 4, 2026, versus $69.66 on August 26, 2026; the promoted $1.6...
Axelrod Research — The Week: Prices Moved, but the Proof Still Did Not
September 5, 2026
Prices moved; the underwriting did not. Across five names, this was a week in which the tape tried to outrun the evidence: the strongest move was NVIDIA, yet...
Axelrod Research — NU: A Higher Price Still Lacks the Credit Proof
September 4, 2026
Nu's payments-to-banking thesis remains plausible, but the evidence still does not establish that credit economics justify paying more for it. With the...
Axelrod Research — PAGS: The Rebound Still Lacks an Underwritten Earnings Case
September 3, 2026
PagBank has rallied, but the evidence still does not support upgrading a broad payments narrative into a buy. The decision today is to HOLD: wait for issuer-...
Axelrod Research — NVDA: The $12.9bn Rumor Still Does Not Change the Call
September 2, 2026
The reported Hugging Face deal still has no primary-source foundation in the research record. At NVIDIA’s $217.44 adjusted close on 1 September 2026, the...
Axelrod Research — SHEL: At $92, an $8bn Sale Rumor Is Not a Buy
September 1, 2026
The reported ~$8bn sale of Shell chemical assets is still not an investable thesis. With SHEL at $92.3748 at 7:02 a.m. ET on 1 September 2026, the right call...
Axelrod Research — AAPL: Apple Pay Still Does Not Earn Its Own Valuation
August 30, 2026
Apple Pay may own the customer screen, but Apple still does not disclose enough payments economics to value that position separately. With AAPL closing at...
Older archives